Abstract
Acquired deficiency of antithrombin (AT), which in some patients could lead to thrombosis, has been a serious side effect of protocols which incorporate E. coli L-asparaginase (ASP) for the treatment of acute lymphoblastic leukaemia (ALL). In a longitudinal, prospective, non-randomized study children with ALL (n=27) were treated according to the protocol ALL-BFM-90. During the induction phase using prednisone, vincristine, daunorubicin and ASP, AT substitution was performed in 15/27 patients, when their plasma concentration decreased below 60% of normal with a concomitant increase of D-dimer formation. After the administration of the AT concentrate the patients, plasma concentration of AT increased and remained elevated after 18, 48, and 72 h. In addition, the plasma concentration of enhanced thrombin generation, D-dimer formation and plasminogen activator inhibitor 1 decreased towards normal levels. Although the observed laboratory findings may serve as evidence for a possible clinical benefit of AT substitution during ASP treatment, further randomized studies are requested to evaluate whether the use of prophylactic AT administration could reduce the incidence of thromboembolic events in childhood acute leukaemia.
References
Apr 1, 1975·Thrombosis Research·O R OdegardU Abildgaard
Jul 1, 1992·Klinische Pädiatrie·A H SutorH Riehm
Mar 1, 1991·American Journal of Hematology·H AsakuraT Matsuda
Apr 1, 1990·British Journal of Haematology·L GugliottaS Tura
Feb 15, 1985·Cancer·O KucukR M Vazquez
Mar 1, 1985·The Journal of Clinical Investigation·M ColucciD Collen
Jun 1, 1982·The Journal of Pediatrics·J R PriestJ R Edson
Feb 1, 1994·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·M G MazzucconiF Mandelli
Jan 1, 1994·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·M AndrewL Mitchell
Jan 1, 1993·Circulation Research·H Noda-HeinyB E Sobel
Feb 15, 1993·Thrombosis Research·F RodeghieroP M Mannucci
Aug 1, 1983·Thrombosis Research·J ChmielewskaB Wiman
Citations
May 2, 2002·Pediatrics International : Official Journal of the Japan Pediatric Society·Teruaki HongoKazuhiro Ueda
May 2, 2002·Medical and Pediatric Oncology·Ellen RuudFinn Wesenberg
Jul 4, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Meryem AlbayrakUlker Koçak
Oct 24, 2014·Thrombosis and Haemostasis·V De StefanoE Rossi
Apr 15, 2016·Leukemia & Lymphoma·Katrina FarrellMike Leach
Feb 22, 2017·Frontiers in Pediatrics·Richard H Ko, Courtney D Thornburg
Feb 1, 2018·British Journal of Haematology·Keith R SibsonUNKNOWN British Society for Haematology
Feb 16, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Inge M AppelRob Pieters
Oct 27, 2012·Leukemia·E TrueloveB J Hunt
Sep 24, 2013·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Susanna RantaAnne M-T Mäkipernaa
Feb 27, 1999·Leukemia & Lymphoma·S R AlbertsT E Witzig
Apr 14, 2006·Pharmacogenomics·Simon M LinWarren A Kibbe
Jun 29, 2006·Blood·Vanesa CarusoMaria Benedetta Donati
Jul 5, 2007·British Journal of Haematology·Jeanette H Payne, Ajay J Vora
Aug 15, 2015·Future Oncology·Gaurav Goyal, Vijaya Raj Bhatt
Apr 20, 2006·Pediatric Hematology and Oncology·Canan Ucar, Umran Caliskan
Jul 16, 2005·Leukemia & Lymphoma·Toshihiko ImamuraShinsaku Imashuku
Jan 25, 2003·British Journal of Haematology·Nethnapha ParedesAnthony K C Chan
Feb 1, 2013·Thrombosis and Haemostasis·Mandy N LauwBart J Biemond
Mar 8, 2021·Cancer Chemotherapy and Pharmacology·Sarah M KashanianAshkan Emadi
Jun 27, 2000·Leukemia Research·J E BushmanF C Church